WASHINGTON — U.S. regulators are allowing the release of 10 million doses of Johnson & Johnson’s COVID-19 vaccine from a troubled Baltimore factory.
However, material to make many more doses must be thrown out because of possible contamination, according to a person familiar with the decision.
The FDA announced Friday it had determined that two batches from the plant could be released. But it says several other batches are not suitable for use and additional batches are still under review. The doses originated at an Emergent BioSolutions factory, known as Bayview, that is making the vaccine for J&J.
A second person familiar with the decision confirmed it would allow for 10 million doses to be released. Both people spoke to the AP on condition of anonymity because they weren’t authorized to release details about it ahead of its announcement.